Kyntra Bio, Inc. (KYNB)
7.13
-0.17
(-2.33%)
USD |
NASDAQ |
Mar 20, 16:00
7.15
+0.02
(+0.28%)
After-Hours: 20:00
Kyntra Bio Research and Development Expense (Quarterly) : 7.268M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 0.486M |
| Perspective Therapeutics, Inc. | 21.91M |
| Gossamer Bio, Inc. | 48.93M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |